Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000862366 | SCV001002862 | benign | Charcot-Marie-Tooth disease axonal type 2O | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001597223 | SCV001831802 | benign | not provided | 2019-07-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002363212 | SCV002661442 | likely benign | Inborn genetic diseases | 2020-06-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV001597223 | SCV004237829 | likely benign | not provided | 2023-11-16 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001597223 | SCV004699602 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | DYNC1H1: PP2, BP4, BS1 |